August 26, 2015

Important Legislation Could Mean More Precise Cancer Care

The 21st Century Cures Act [HR 6] passed in the House on July 10, 2015 will hopefully move to the Senate for confirmation in the Fall 2015. This important legislation incorporates the President’s Precision Medicine Initiative to focus more aggressively … Read More


August 16, 2015

Scientific Advisory Council Welcomes New Members

Composed of leading researchers and innovators in the field of cancer research, ACGT’s Scientific Advisory Council sets research priorities for ACGT, provides peer review of grant proposals and oversees ACGT-funded studies. Under the new chairmanship of Joseph Glorioso, PhD, four new … Read More

Bob Nevis, On Par

January 16, 2015

Back on Par

In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, the cancer had resisted every possible treatment and had infiltrated his bone marrow, paralyzing his … Read More

Lung Cancer

February 26, 2014

Dr. Jack Roth’s Patient with Adenocarcinoma

I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More


December 1, 2013

By the Numbers

ACGT is the nation’s only non-profit exclusively dedicated to gene and cell therapies for treating cancer.  To date, ACGT has provided over $24 million in grants to top oncologists and funded breakthrough clinical trials that save lives.  Learn more about ACGT … Read More

Dr. Sadelain

October 17, 2013

Future of Gene Therapy

Dr. Michel Sadelain, ACGT Research Fellow, talks about the future of gene therapies for cancer treatment. When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the Harvard Club in NYC. … Read More

Dr. Laurence Cooper

October 17, 2013

Philanthropy Key to Fighting Cancer

Dr. Laurence Cooper, ACGT Research Fellow, emphasizes the need for philanthropy and private funding in the fight against cancer. . When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the … Read More

The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.

Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue.  ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council,  have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.

100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.